“I'm at breaking point”; Exploring pharmacists' resilience, coping and burnout during the COVID-19 pandemic

Abstract

Background There is a lack of evidence on how the multimodal dynamic process of resilience has impacted personal adaptation of frontline healthcare professionals, working under extreme pressure during the COVID-19 global pandemic. Objectives To explore resilience, burnout and wellbeing for UK pharmacists in patient-facing roles, including individual and organisational factors that align to the ABC-X theoretical model of the dynamic process of resilience. Methods A non-experimental pragmatist research design was adopted, with a cross-sectional online survey distributed via social media and professional networks between June and July 2020. Quantitative data aligned to a positivist research paradigm was collected using validated scores, to statistically analyse wellbeing, burnout and resilience. Qualitative textual data, consistent with an interpretivist research paradigm, were analysed following an inductive thematic approach. Results A total of 199 surveys from pharmacists working within community, hospital and GP sectors were analysed. Wellbeing scores were strongly correlated to resilience scores. Wellbeing and resilience scores were both inversely correlated with burnout scores. Two-thirds of participants were classified as high-risk within the burnout scales. Key stressors were highlighted by participants, who described how individual resources and perceptions shaped their experience, which overall contributed to their burnout. Organisations that supported pharmacists embraced change and quickly adopted new ways of working, such as teleconsultations, flexible and remote working, redesign of workflow, alongside clear guidance. However, there was also reported frustration at lack of, slow or conflicting guidance from employers. Conclusions This study adds to the growing evidence base for how individuals are affected by adverse events in a dynamic environment, alongside the role that employers can play in supporting individual and organisational resilience. It provides an opportunity to learn from pharmacists' responses to the COVID-19 pandemic, and a call to action for healthcare organisations to rebuild and invest resources into sustained support for staff wellbeing.

Pharmacist and patient experiences of primary care during the COVID-19 pandemic: An interview study

“…Stress has long been recognised as a key factor in patient safety events, and the increased levels of stress and burnout experienced by frontline healthcare staff during the pandemic are well documented. 25 , 26 A recent survey study by this research group found that 39% of pharmacists and 35% of GPs surveyed reported an increase in medication safety incidents during the pandemic. 13 Findings from this study suggest that for pharmacists, workflow changes and stress may have been potential contributory factors to this increase in incidents perceived by our participants.…”

Increased self-reported pharmacist prescribing during the COVID-19 pandemic: Using the Theoretical Domains Framework to identify barriers and facilitators to prescribing

“…This domain may become a larger area of concern in the future, as risk of healthcare professional burnout appears to be increasing with the COVID-19 pandemic. 71 , 72 , 73 …”

Global resilience and new strategies needed for antimicrobial stewardship during the COVID‐19 pandemic and beyond

“…A UK‐wide survey showed that COVID‐19 had a significant negative impact on local ASP activities that included auditing antimicrobials, quality improvement initiatives, education, ASP meetings, and multidisciplinary ward rounds. 41 One UK pharmacy survey classified respondents as high‐risk within the burnout scale and several pharmacists stated “I'm at a breaking point.” 42 Resilience and persistence led to new innovation during COVID‐19 that broadly falls into four main categories: (i) digitization, (ii) workforce changes, (iii) service integration, and (iv) person‐centered care. 43…”

“…41 One UK pharmacy survey classified respondents as high-risk within the burnout scale and several pharmacists stated "I'm at a breaking point." 42 Resilience and persistence led to new innovation during COVID-19 that broadly falls into four main categories: (i) digitization, (ii) workforce changes, (iii) service integration, and (iv) person-centered care. 43 Although competing priorities to deal with the pandemic have led to reduced focus on global strategies to tackle ASP, there have been…”